SCHEMBL18969641

SCHEMBL18969641

CCOC(=O)c1cc(-c2ccccc2)n(C2CCCC2)n1

nearest known ligand 0.54

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
FAAH O00519 10/20 0.54
CA9 Q16790 1/20 0.52
MGLL Q99685 3/20 0.52
FABP3 P05413 3/20 0.50
FABP4 P15090 3/20 0.50
TDP1 Q9NUW8 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1131946 0.87 FAAH (0.54) FAAHMGLLFABP3FABP4
SCHEMBL18939233 0.85 APLNR (0.50) FAAHCA9MGLLFABP3FABP4
SCHEMBL29771925 0.85 APLNR (0.50) FAAHCA9MGLLFABP3FABP4
SCHEMBL18969643 0.83 APLNR (0.51) FAAHFABP3FABP4TDP1
SCHEMBL18939425 0.82 RPA1 (0.54) FAAHFABP3FABP4
SCHEMBL22506642 0.81 FAAH (0.48) FAAHCA9
SCHEMBL29771936 0.80 APLNR (0.53) FAAHFABP3FABP4
SCHEMBL18939220 0.80 APLNR (0.53) FAAHFABP3FABP4
SCHEMBL18939308 0.80 KMT2A (0.46) FAAH
SCHEMBL30979687 0.79 FAAH (0.45) FAAHMGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-RE49594-E1 Apelin receptor (APJ) agonists and uses thereof RESEARCH TRIANGLE INSTITUTE (US) 2023-08-01 US disclosed
US-RE49594-E1 Apelin receptor (APJ) agonists and uses thereof RESEARCH TRIANGLE INSTITUTE (US) 2023-08-01 US disclosed
US-11535630-B2 Apelin receptor (APJ) agonists and uses thereof RESEARCH TRIANGLE INSTITUTE (US) 2022-12-27 US disclosed
US-10954247-B2 Apelin receptor (APJ) agonists and uses thereof RESEARCH TRIANGLE INSTITUTE (NC) 2021-03-23 US disclosed
US-20210070767-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF RESEARCH TRIANGLE INSTITUTE 2021-03-11 US disclosed
US-20170166577-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF RESEARCH TRIANGLE INSTITUTE 2017-06-15 US disclosed
US-20170166577-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF RESEARCH TRIANGLE INSTITUTE 2017-06-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170166577-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF APLNR, AP1G1, APMAP FAAH 473/4885CA9 3273/4885MGLL 1904/4885
US-11535630-B2 Apelin receptor (APJ) agonists and uses thereof APLNR, AP1G1, APMAP FAAH 473/4885CA9 3273/4885MGLL 1904/4885
US-20210070767-A1 APELIN RECEPTOR (APJ) AGONISTS AND USES THEREOF APLNR, AP1G1, APMAP FAAH 473/4885CA9 3273/4885MGLL 1904/4885
US-10954247-B2 Apelin receptor (APJ) agonists and uses thereof APLNR, AP1G1, APMAP FAAH 473/4885CA9 3273/4885MGLL 1904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.